January 2014 in “IOSR journal of pharmacy” Adalimumab can cause complete hair loss in rare cases.
January 1991 in “Journal of Pediatric Health Care” Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.
May 2026 in “Archives of Dermatological Research” Alopecia areata in Asia causes significant hair loss and psychological distress, with high costs and a need for more research.
May 2026 in “Jurnal Sehat Indonesia (JUSINDO)” Low vitamin D levels may worsen or cause alopecia areata.
Removing silicone breast implants may improve symptoms of autoimmune/inflammatory syndrome.
April 2026 in “Boletín Médico Del Hospital Infantil de México (English Edition)” Most kids with alopecia areata have other health issues, often allergies or skin conditions.
Microneedling may help treat some autoimmune skin conditions, but more research is needed.
Improving oral health may help hair regrowth in children with alopecia areata.
April 2026 in “International Journal of Homoeopathic Sciences” Homoeopathic treatment using Opium helped regrow beard hair by addressing mental symptoms.
April 2026 in “International Journal of Homoeopathic Sciences” Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.
March 2026 in “Immunological Medicine” Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.
March 2026 in “Expert Opinion on Pharmacotherapy” JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.
March 2026 in “International journal of Nutrition Pharmacology Neurological Diseases” Hair loss is common but often untreated in Saudi Arabia, needing more public awareness and better access to care.
March 2026 in “Skin Appendage Disorders” Belatacept may be a promising treatment for alopecia areata.
February 2026 in “Boletín Médico del Hospital Infantil de México” Children with alopecia areata often have related health issues like allergies, autoimmune diseases, or mental health conditions.
February 2026 in “Annals of Case Reports” Tofacitinib helped a patient regrow hair after 40 years of total hair loss.
February 2026 in “Stem Cell Research & Therapy” Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.
February 2026 in “Journal of Drugs in Dermatology” Janus kinase inhibitors are effective and safe for treating alopecia areata.
A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.
January 2026 in “International Research Journal of Modernization in Engineering Technology and Science” Alopecia areata causes patchy hair loss and is often treated with corticosteroids.
January 2026 in “Forum Dermatologicum” JAK inhibitors and combination therapies show promise for treating severe alopecia areata.
January 2026 in “Immunity & Inflammation” Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.
January 2026 in “International Journal of Research and Innovation in Applied Science” Ayurvedic treatment may help manage alopecia areata.
December 2025 in “International Journal of Research in Ayurveda and Pharmacy” Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.
December 2025 in “Cureus” Alopecia areata and psoriasis vulgaris can inhibit each other in the same areas.
December 2025 in “BENTHAM SCIENCE PUBLISHERS eBooks” Secondary plant metabolites may offer a safer treatment for alopecia areata.
Children with alopecia areata need supportive care and off-label treatments due to a lack of approved options.
November 2025 in “Biomedicines” Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.
November 2025 in “Figshare” SQSTM1 is linked to increased risk of alopecia areata.
November 2025 in “Journal of Investigative Dermatology” Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.